KR20050088998A - 2 이상의 핵산서열 간의 비의 정량화 방법 - Google Patents

2 이상의 핵산서열 간의 비의 정량화 방법 Download PDF

Info

Publication number
KR20050088998A
KR20050088998A KR1020057008235A KR20057008235A KR20050088998A KR 20050088998 A KR20050088998 A KR 20050088998A KR 1020057008235 A KR1020057008235 A KR 1020057008235A KR 20057008235 A KR20057008235 A KR 20057008235A KR 20050088998 A KR20050088998 A KR 20050088998A
Authority
KR
South Korea
Prior art keywords
nucleic acid
interest
ratio
amount
amplification
Prior art date
Application number
KR1020057008235A
Other languages
English (en)
Korean (ko)
Inventor
에블린 카테리나 안나 클라시나 팀머만스
보브 반 게멘
Original Assignee
프리마겐 홀딩 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02079673A external-priority patent/EP1418241A1/fr
Application filed by 프리마겐 홀딩 비.브이. filed Critical 프리마겐 홀딩 비.브이.
Publication of KR20050088998A publication Critical patent/KR20050088998A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020057008235A 2002-11-08 2003-11-07 2 이상의 핵산서열 간의 비의 정량화 방법 KR20050088998A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42505502P 2002-11-08 2002-11-08
EP02079673.6 2002-11-08
EP02079673A EP1418241A1 (fr) 2002-11-08 2002-11-08 Procédé de quantifier le rapport de deux séquences d'acides nucléiques
US60/425,055 2002-11-08

Publications (1)

Publication Number Publication Date
KR20050088998A true KR20050088998A (ko) 2005-09-07

Family

ID=32313842

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057008235A KR20050088998A (ko) 2002-11-08 2003-11-07 2 이상의 핵산서열 간의 비의 정량화 방법

Country Status (6)

Country Link
JP (1) JP2006505268A (fr)
KR (1) KR20050088998A (fr)
AU (1) AU2003279621A1 (fr)
CA (1) CA2448769A1 (fr)
NZ (1) NZ540144A (fr)
WO (1) WO2004042085A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101414714B1 (ko) * 2007-11-20 2014-07-03 삼성전자주식회사 경쟁적 증폭 반응을 이용하여 표적 핵산을 검출하는 방법

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013970B1 (ru) * 2005-03-24 2010-08-30 Тромбоджиникс Н.В. Антитела к плацентарному фактору роста и способы их применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040034582A (ko) * 2000-12-04 2004-04-28 프리마겐 홀딩 비.브이. 내공생체 세포소기관의 시험 및 그것에 의해 동정할 수있는 화합물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101414714B1 (ko) * 2007-11-20 2014-07-03 삼성전자주식회사 경쟁적 증폭 반응을 이용하여 표적 핵산을 검출하는 방법

Also Published As

Publication number Publication date
WO2004042085A2 (fr) 2004-05-21
WO2004042085A3 (fr) 2004-08-05
AU2003279621A1 (en) 2004-06-07
JP2006505268A (ja) 2006-02-16
NZ540144A (en) 2008-08-29
CA2448769A1 (fr) 2004-05-08

Similar Documents

Publication Publication Date Title
US6967016B2 (en) Method of determining therapeutic activity and/or possible side-effects of a medicament
US20080182260A1 (en) Method for quantifying a ratio between at least two nucleic acid sequences
US8623602B2 (en) Lysis and reverse transcription for MRNA quantification
JP5091856B2 (ja) 生存能力関連分子の改善された検出方法
AU3867199A (en) Quantitative analysis of gene expression
KR20050088998A (ko) 2 이상의 핵산서열 간의 비의 정량화 방법
Mateescu et al. Increased MIG-6 mRNA transcripts in osteoarthritic cartilage
US20130034850A1 (en) Marker for detecting myogenic disease and detection method using the same
US20230193405A1 (en) Compositions and methods for detection of candida auris
US20170166953A1 (en) Methods and kits for joining fragmented nucleic acids together
EP1418242A1 (fr) Procédé de quantification du rapport au moins de deux séquences acide nucléique
KR20230035317A (ko) 샘플내 미리-결정된 rna 서열의 존재를 결정하기 위한 등온 실시간 pcr 방법
Kocen MiRNA Biomarkers from Human Cardiac Stress Model
Matsui et al. Rapid nonradioactive in-situ hybridization for mRNA detection of calcineurin in rat brain using PCR DNA probe

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination